Industry Symposia during TRI 2026 in Berlin
InS-01 | Neuroplasticity and Neuroinflammation: Uncovering the Links Between Tinnitus, Cognitive Impairment, and Affective Disorders
Sponsored by: Dr. Willmar Schwabe GmbH & Co. KG
Date & Time
16 September 2026 | 13:00–14:00
Location
Lecture Hall "Innere Medizin"
Moderator
Prof. Dr. Birgit Mazurek
Berlin, Germany
Speakers
Prof. Dr. rer. nat. Anne Eckert
University of Basel, Switzerland
Presentation: Neuroinflammation and Neuroplasticity – Mechanisms Across Tinnitus, Cognition, and Anxiety
Prof. Emeritus Siegfried Kasper
Vienna, Austria
Presentation: Across Sound and Mind: Clinical Lessons from EGb 761® and Silexan® in Tinnitus, Cognition and Anxiety
Session Overview
This symposium explores the emerging connections between neuroplasticity, neuroinflammation, tinnitus, cognitive impairment, and affective disorders. Leading experts in neuroscience and psychiatry will discuss underlying mechanisms and clinical perspectives that may advance integrated approaches to brain health, cognition, anxiety, and tinnitus management.
InS-02 | Digital Therapeutics (DTx) in Tinnitus Management
Sponsored by: Berlin Health Club
Date & Time
16 September 2026 | 15:30–16:30
Location
Lecture Hall "Innere Medizin"
Moderator
Rainer Hainzlmaier
Berlin, Germany
Speakers
Prof. Dr. Rüdiger Pryss
Würzburg, Germany
Presentation: Clinical Efficacy of Digital Therapeutics (DTx)
Dr. Michael Golenhofen
Germany
Presentation: Digital Therapeutics in Tinnitus Care: An ENT Specialist's Perspective
Prof. Dr. Winfried Schlee
St. Gallen, Switzerland
Presentation: What’s Next for Digital Therapeutics in Tinnitus Management
Session Overview
Digital therapeutics (DTx) are emerging as innovative, evidence-based treatment options for tinnitus. This symposium brings together leading experts from research and clinical practice to discuss the effectiveness, practical implementation, and future potential of digital therapeutic approaches in tinnitus care. Participants will gain insights into current clinical evidence, real-world ENT applications, and upcoming developments shaping the future of digital tinnitus management.
InS-03 | Hearing Care Today and Tomorrow
Sponsored by: Sonova
Date & Time
17 September 2026 | 12:45–13:45
Location
Lecture Hall "Innere Medizin"
Moderator
To be announced
Speakers
Dr. Maren Stropahl
Germany
Presentation: Barriers and Facilitators of Hearing Care Adoption
Dr. Raffael Schmitt
Germany
Presentation: Benefits of Hearing Care Beyond Speech Understanding
Stefan Launer
Germany
Presentation: Current and Future Trends of Hearing Technology
Session Overview
This industry symposium explores current challenges and future opportunities in hearing care. Experts will discuss factors influencing the adoption of hearing solutions, the broader benefits of hearing care beyond speech intelligibility, and emerging innovations that are shaping the future of hearing technology and patient-centered hearing healthcare.
InS-04 | Real-World Experience of 1,500 Patients Across 20 Clinics Demonstrates Clinically Significant Improvement in Tinnitus with Lenire Bimodal Treatment
Sponsored by: Neuromod
Date & Time
18 September 2026 | 12:45–13:45
Location
Lecture Hall "Innere Medizin"
Moderator
To be announced
Speakers
Dr. Ross O'Neill
Dublin, Ireland
Emma Meade
Dublin, Ireland
Dr. Jason Leyendecker
Edina, USA
Dr. Melissa Wikoff
Marietta, USA
Session Overview
This industry symposium presents real-world evidence from 1,500 patients treated across 20 clinics, demonstrating clinically significant improvements in tinnitus outcomes with Lenire® bimodal neuromodulation therapy. International experts and clinicians will share insights from clinical practice, patient experiences, and implementation strategies, highlighting the growing role of bimodal treatment approaches in tinnitus management.
